Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries

Autor: Anders Mattiasson, Jannie Wickstrøm, Ian Milsom, Carl Gustaf Nilsson, Sigurd Kulseng-Hansen, Susanne Maigaard Axelsen

Publikováno v: Milsom, I, Kulseng-Hansen, S, Mattiasson, A, Nilsson, C G, Wickstrøm, J & Axelsen, S M 2009, ' Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries ', Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 6, pp. 693-9 . https://doi.org/10.1080/00016340902849738

Udgivelsesdato: 2009-null OBJECTIVE: The purpose of the present analysis was to analyze and compare the cost-effectiveness of solifenacin flexible dosing (5-10 mg) with tolterodine 4 mg sustained release (SR) or placebo (assumed to be comparable to n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf90b7ce8c1e82392a214d1c904ff0aa
https://doi.org/10.1080/00016340902849738

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

Autor: Jannie Wickstrøm, S Holmstrom, P Buchholz, John G. Walt, Mark Aagren

Publikováno v: Current Medical Research and Opinion. 22:897-905

The objective of this cost-effectiveness analysis is to evaluate cost-effectiveness ratios of the intraocular pressure (IOP)-lowering agents bimatoprost, latanoprost and timolol in five major European countries: France, Germany, Italy, Spain and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570b53163220536ad3be01cc02f2c9f2
https://doi.org/10.1185/030079906x104687

Future health care costs—do health care costs during the last year of life matter?

Autor: Niels Serup-Hansen, Jannie Wickstrøm, Ivar Sønbø Kristiansen

Publikováno v: Serup-Hansen, N, Wickstrøm, J & Kristiansen, I S 2002, ' Future health care costs-do health care costs during the last year of life matter? ', Health Policy, vol. 62, pp. 161-72. . https://doi.org/10.1016/s0168-8510(02)00015-5

While some studies have shown a considerable effect of ageing upon future health care costs, others indicate small or no effects. Moreover, studies have shown that age-related increases in health care costs in part can be explained by high costs in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ab199b8f42c2636f6ab52d22f529f0
https://doi.org/10.1016/s0168-8510(02)00015-5